Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

Press releases published on June 18, 2026

Jun. 18, 2026

Whole Slide Imaging Market to reach USD 2.67 Billion by 2035 at 6.85% CAGR

Indeterminate EIN Presswire

Jun. 18, 2026

Acute Coronary Syndrome Market to reach USD 27.61 Billion by 2035 at 7.14% CAGR

Indeterminate EIN Presswire

Jun. 18, 2026

Topical Drug Delivery Market to reach USD 269.50 Billion by 2035 at 7.25% CAGR

Indeterminate EIN Presswire

Jun. 18, 2026

Bile Duct Cancer Market to reach USD 9.47 Billion by 2035 at 8.1% CAGR

Indeterminate EIN Presswire

Jun. 18, 2026

Veterinary Medicine Market to reach USD 95.63 Billion by 2035 at 7.48% CAGR

Indeterminate EIN Presswire

Jun. 18, 2026

Biological Skin Substitutes Market to reach USD 1,001.04 Million by 2035 at 9.6% CAGR

Indeterminate EIN Presswire

Jun. 18, 2026

Hi*Ball Energy erobert Großbritannien und wird zum Vorreiter des neuen „Clean Energy“-Trends

Indeterminate GlobeNewswire

Jun. 18, 2026

Hi*Ball Energy fait son entrée au Royaume-Uni et redéfinit les codes de la boisson énergisante

Indeterminate GlobeNewswire

Jun. 18, 2026

Teva Releases Q2 2026 Aide Memoire

Indeterminate GlobeNewswire

Jun. 18, 2026

Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome

Indeterminate GlobeNewswire

Jun. 18, 2026

Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET

Indeterminate GlobeNewswire

Jun. 18, 2026

Autonomix Announces Reverse Stock Split

Indeterminate GlobeNewswire

Jun. 18, 2026

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 18, 2026

Vireo Growth Inc. Completes Acquisition of Equity Interest in Maryland Dispensaries

Indeterminate GlobeNewswire

Jun. 18, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 18, 2026

Memento Medicines Launches with $93 Million Series A Financing to advance Tie2 Agonist and VEGF Inhibitor Bispecific Antibody Therapy for Retinal Diseases 

Indeterminate GlobeNewswire

Jun. 18, 2026

Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards

Indeterminate GlobeNewswire

Jun. 18, 2026

TretinoinCream.com Launches Medical Provider-Led Telehealth Platform for Prescription Skincare

Indeterminate GlobeNewswire

Jun. 18, 2026

CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity

Indeterminate GlobeNewswire

Jun. 18, 2026

Constantiam Biosciences and Cincinnati Children’s Collaborate to Accelerate First-in-Class Neuronopathic Gaucher Disease Therapies

Indeterminate GlobeNewswire